Agios Pharmaceuticals Inc. (AGIO)

62.37
3.20 4.90
NASDAQ : Health Technology
Prev Close 65.59
Open 65.56
Day Low/High 62.20 / 65.56
52 Wk Low/High 41.63 / 99.82
Volume 352.31K
Avg Volume 490.90K
Exchange NASDAQ
Shares Outstanding 58.40M
Market Cap 3.81B
EPS -6.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Agios Pharmaceuticals Inc.

(Graphic: Business Wire)

(Graphic: Business Wire)

Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced that IDHIFA ® (enasidenib) was granted approval from the U.

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Agios Pharmaceuticals Inc.

TheStreet Quant Rating: D (Sell)